Press Room

Share

House Passes 21st Century Cures; Senate Should Take Quick Action

Bipartisan Deal Gives $4.8 Billion to National Institutes of Health

November 30, 2016

WASHINGTON, D.C.—November 30, 2016—Tonight the U.S. House of Representatives overwhelmingly approved the bipartisan 21st Century Cures bill, which includes a $4.8 billion funding increase for the National Institute of Health, including the National Cancer Moonshot Initiative.

A statement from Chris Hansen, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:

“We commend committee members from both parties—in particular Chairman Fred Upton (R-MI) and Rep. Diana DeGette (D-CO)—for their more than year-long dedication to passing this legislation and increasing funding for cancer research. Today, thanks to Reps. Upton and DeGette as well as all those who voted in favor of the bill, millions of cancer patients, survivors and their families are one step closer to accelerated progress in new diagnostic tools and improved cancer treatments.

“By providing funding to the National Institutes of Health (NIH), specifically for the National Cancer Moonshot, Congress can ensure cutting-edge cancer research makes it from the laboratory to the patients who need it most.

“Today’s House vote is just the first step, however, toward making this funding and its potential promise a reality. Never before have we been so close to making so much progress in such a short amount of time against this disease. Now is the time for action.

“On behalf of all those touched by cancer, we urge the Senate to quickly take up and pass Cures and for appropriators to allocate the requisite funding in the upcoming continuing resolution.”

More Press Releases AboutCancer Research Funding

Media Contacts

Allison Miller
[email protected]
(205) 401-7420
Alissa Crispino
[email protected]
(202) 661-5772

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more